NASDAQ: PLYX
Polaryx Therapeutics Inc Stock Ownership - Who owns Polaryx Therapeutics?

Insider buying vs selling

Have Polaryx Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
G. Michael LandisChief Financial Officer2026-02-182,867$2.79
$7.99kBuy

1 of 1

PLYX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PLYX insiders and whales buy or sell their stock.

PLYX Shareholders

What type of owners hold Polaryx Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Alex Keun Mo Yang51.00%24,144,796$133.76MInsider
Andrew John O.1.00%471,808$2.61MInsider
G. Michael Landis0.48%228,225$1.26MInsider
Lisa Bollinger0.32%150,358$832.98kInsider

1 of 1

PLYX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
AARD49.36%46.96%Net Buying
ACET29.18%70.82%Net BuyingNet Selling
ABUS30.49%69.51%
ABVC3.36%82.65%
AAPG0.01%10.77%

Polaryx Therapeutics Stock Ownership FAQ

Who owns Polaryx Therapeutics?

Polaryx Therapeutics (NASDAQ: PLYX) is owned by 0.00% institutional shareholders, 52.80% Polaryx Therapeutics insiders, and 47.20% retail investors. Alex Keun Mo Yang is the largest individual Polaryx Therapeutics shareholder, owning 24.14M shares representing 51.00% of the company. Alex Keun Mo Yang's Polaryx Therapeutics shares are currently valued at $133.76M.

If you're new to stock investing, here's how to buy Polaryx Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.